Grants and Contributions:
Title:
513419
Agreement Number:
513419
Agreement Value:
$13,442,000.00
Agreement Date:
Apr 29, 2020 - Sep 30, 2023
Description:
Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to secure an effective therapeutic in response to COVID-19.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
This project will help develop medical counter measures (MCM) and contribute to Canada's ability to secure an effective therapeutic response to COVID-19.
Location:
Sherbrooke, Quebec, CA J1E0M8
Reference Number:
033-2020-2021-Q4-513419
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
805852886
Recipient Type:
For-profit organization
Additional Information:
The Amendment has been completed to extend the project agreement end date from 2031-03-31 to 2031-09-30. The contribution is non-repayable.
Amendment Date
Mar 28, 2023
Recipient's Operating Name:
Immune Biosolutions Inc.
Recipient's Legal Name:
Immune Biosolutions Inc.
Federal Riding Name:
Sherbrooke
Federal Riding Number:
24073
Program:
SIF Stream 1- R&D
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
541710
Amendments: